Bain uses cookies to improve functionality and performance of this site. More information can be found in our Privacy Policy. By continuing to browse this site, you consent to the use of cookies.

We have limited Spanish content available. View Spanish content.

Snap Chart

Post–Covid-19, Doctors Want Both In-Person and Virtual Visits with Sales Reps

The pandemic has more physicians asking for remote support, but the majority will still want some in-person visits.

Snap Chart

Post–Covid-19, Doctors Want Both In-Person and Virtual Visits with Sales Reps
en

So much has gone virtual due to Covid-19, but physicians still value in-person sales and service visits, according to Bain & Company’s latest survey of frontline providers, conducted with Dynata. Prior to Covid, about three-fourths of physicians preferred face-to-face engagement with medtech and pharmaceutical reps. Today, more are open to virtual approaches and a reduction in visit frequency, but a majority still prefer at least some in-person interaction once the pandemic passes. To address these shifting customer preferences, medtech and pharma companies will need to continue in-person interactions while adding digital capabilities.

Related Insights

Coronavirus

As the global pandemic deepens and the human cost of Covid-19 rises, the novel coronavirus outbreak is sending shocks through the world economy. But across industries, companies can take action now to protect their employees and customers and minimize the economic damage.

About the Research

Data powered by Dynata, a leading global first-party data and insights platform.

Tags

Want to continue the conversation

We help global leaders with their organization's most critical issues and opportunities. Together, we create enduring change and results